Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Bigner

Showing results (1-10 of 373) with videos related to

Pageof 38
Sort By:
Journal of Neurosurgery|December 1, 1992
M. Stephen Mahaley, Jr., M.D., Ph.D., 1932-1992D D Bigner
Neurosurgery|September 1, 1981
Biology of gliomas: potential clinical implications of glioma cellular heterogeneityD D Bigner
Neurologic Clinics|November 1, 1985
Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomasY Lee, D D Bigner
Journal of Neuro-Oncology|October 1, 1990
In memoriam Lucien J. Rubinstein, M.D. (1924-1990)R Barnard, D D Bigner
Archives of Pathology & Laboratory Medicine|July 1, 1984
A word of caution in the use of neuron-specific enolase expression in tumor diagnosisG Dranoff, D D Bigner
Brain Pathology (Zurich, Switzerland)|July 1, 1994
Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerationsR E McLendon, D D Bigner
Journal of Neurosurgery|July 1, 1985
Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumorsD E Bullard, D D Bigner
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1971
Neurological disorders with abnormalities of immunoglobulin metabolismD D Bigner, D E McFarlin
Cancer Research|October 1, 1973
Specificity, cross-reactivity, and affinity of 125I-labeled antiglioma antibodies for monolayers of cultured glioma cellsE D Day, D D Bigner
Journal of Neuroimmunology|September 1, 1981
Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE inductionC J Wikstrand, D D Bigner
Pageof 38

Showing results (1-10 of 373) with videos related to

Sort By:
Pageof 38
Journal of Neurosurgery|December 1, 1992
M. Stephen Mahaley, Jr., M.D., Ph.D., 1932-1992D D Bigner
Neurosurgery|September 1, 1981
Biology of gliomas: potential clinical implications of glioma cellular heterogeneityD D Bigner
Neurologic Clinics|November 1, 1985
Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomasY Lee, D D Bigner
Journal of Neuro-Oncology|October 1, 1990
In memoriam Lucien J. Rubinstein, M.D. (1924-1990)R Barnard, D D Bigner
Archives of Pathology & Laboratory Medicine|July 1, 1984
A word of caution in the use of neuron-specific enolase expression in tumor diagnosisG Dranoff, D D Bigner
Brain Pathology (Zurich, Switzerland)|July 1, 1994
Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerationsR E McLendon, D D Bigner
Journal of Neurosurgery|July 1, 1985
Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumorsD E Bullard, D D Bigner
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1971
Neurological disorders with abnormalities of immunoglobulin metabolismD D Bigner, D E McFarlin
Cancer Research|October 1, 1973
Specificity, cross-reactivity, and affinity of 125I-labeled antiglioma antibodies for monolayers of cultured glioma cellsE D Day, D D Bigner
Journal of Neuroimmunology|September 1, 1981
Hyperimmunization of non-human primates with BCG-CW and cultured human glioma-derived cells. Production of reactive antisera and absence of EAE inductionC J Wikstrand, D D Bigner
Pageof 38